The FTC's health products compliance guidance explains that an advertiser must possess adequate substantiation for a health-related claim before making it, and that the type of evidence required scales with how strong the claim is. A specific disease or outcome claim generally calls for more rigorous evidence than a general wellness statement, and testimonials do not substitute for that evidence.
This standard applies regardless of who is making the claim. A distributor's website, social media account, or sales material can create FTC exposure independently of what a manufacturer states in its own labeling, and silence from one party does not excuse unsubstantiated claims made by another in the same supply chain.
For a biologics distributor, the practical implication is that marketing content should stick to what can be documented: composition, processing description, testing performed, and regulatory posture, rather than claims about what a product does for a disease or symptom. Clinics reviewing a supplier's marketing can treat the presence of disease or outcome claims as a flag worth raising before placing an order.
Clinics should know that unsubstantiated health claims anywhere in a supplier's marketing create regulatory exposure for both the supplier and, potentially, the clinic that relies on those claims.